journal cover

FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease

Transplantation

Apr 17, 2003

Murad Y YunusovR A Nash

Abstract

Graft-versus-host (GVH) reactions contribute to stable engraftment of allogeneic hematopoietic stem cell transplants. It was hypothesized that the in vivo expansion of recipient dendritic cells (DC) with the administration of ligand for Flt3 (FL) could promote allogeneic engraftment aft...read more

Mentioned in this Paper

Sialadenitis
Neutrophil Band Cells
Decreased Immunologic Activity [PE]
FLT3LG gene
Immunologic Adjuvants
Peripheral Blood
Mobista
Graft Acceptance
Peripheral Blood Mononuclear Cells (Lab Test)
Science of Morphology
Paper Details
References
  • References
  • Citations10
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations10
1

Similar Papers Found In These Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Immune Tolerance

Immune tolerance happens when the immune system is not responsive to a substance or organism and does not elicit an immune response. This is a normal physiological response for some antigens, especially when detecting self from non-self. This has been a potential area of therapy for some disorders. Here is the latest research on immune tolerance.

Lymphoid Neoplasms

Lymphoid neoplasms are derived from cells that frequently have features that recapitulate stages of normal b-, t-, and nk-cell differentiation and function. Lymphoid neoplasms include the following morphologic types: follicular center cell, lymphoblast (lymphocytic), immunoblast, plasma cell, and large granular lymphocyte (lgl). Here is the latest research on lymphoid neoplasms.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Hematopoetic Stem Cells

Hematopoietic stem cells (HSCs) are the cells that give rise to blood cells of the myeloid and lymphoid lineage during hematopoiesis. HSC transplantation is an established therapeutic option for both malignant and nonmalignant indications. Here is the latest research.

HSC Transplantation

Hematopoietic stem cell (HCT) transplants have been used as treatment options for some types of cancer including lymphoma and leukemia as well as some immunodeficiency illnesses and congenital abnormalities. Currently research is underway into the potential use of HCTs in genetic disorders. Here is the latest research on HCT transplantation.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Neutrophils

Neutrophils are an essential component of the innate immune response and a major contributor to inflammation. Here is the latest research on neutrophils.

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Related Papers

© 2020 Meta ULC. All rights reserved

FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease

Transplantation

Apr 17, 2003

Murad Y YunusovR A Nash

PMID: 12698076

DOI: 10.1097/01.tp.0000057831.93385.7d

Abstract

Graft-versus-host (GVH) reactions contribute to stable engraftment of allogeneic hematopoietic stem cell transplants. It was hypothesized that the in vivo expansion of recipient dendritic cells (DC) with the administration of ligand for Flt3 (FL) could promote allogeneic engraftment aft...read more

Mentioned in this Paper

Sialadenitis
Neutrophil Band Cells
Decreased Immunologic Activity [PE]
FLT3LG gene
Immunologic Adjuvants
Peripheral Blood
Mobista
Graft Acceptance
Peripheral Blood Mononuclear Cells (Lab Test)
Science of Morphology

Similar Papers Found In These Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation

Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow TransplantationAugust 22, 2003
William J HoganR Storb
Paper Details
References
  • References
  • Citations10
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations10
1
/papers/flt3-ligand-promotes-engraftment-of-allogeneic/12698076